BioHealth News

NYT: Paying for science

NYT: Paying for science

Read More
Alphyn Secures FDA Clearance of Investigational New Drug Application for Atopic Dermatitis Treatment

Alphyn Secures FDA Clearance of Investigational New Drug Application for Atopic Dermatitis Treatment

Read More
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial

CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial

Read More
Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA

Britecyte’s Adipose Tissue Allograft Earns “Safe to Proceed” Status from FDA

Read More
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders

Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders

Read More
Georgetown Research and Innovation Showcase: Connecting Academia, Industry, and Investors

Georgetown Research and Innovation Showcase: Connecting Academia, Industry, and Investors

Read More
Governor Moore Names Harry Coker, Jr. as Maryland Department of Commerce Secretary

Governor Moore Names Harry Coker, Jr. as Maryland Department of Commerce Secretary

Read More
TEDCO Invests in Novel Microdevices

TEDCO Invests in Novel Microdevices

Read More
BHI Board Member Juergen Klenk Discusses the Future of AI in Federal Health with Deloitte AI Institute

BHI Board Member Juergen Klenk Discusses the Future of AI in Federal Health with Deloitte AI Institute

Read More
Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

Oragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment

Read More
Children’s National and Compremium partner on pediatric medtech innovation

Children’s National and Compremium partner on pediatric medtech innovation

Read More
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients

Read More
Baltimore’s Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

Baltimore’s Elixirgen Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

Read More
SSTI – Useful Stats: Which businesses are potentially impacted by the NIH F&A rate change?

SSTI – Useful Stats: Which businesses are potentially impacted by the NIH F&A rate change?

Read More
TEDCO Announces FY2025 SBIR/STTR Proposal Lab Cohort

TEDCO Announces FY2025 SBIR/STTR Proposal Lab Cohort

Read More
View All Posts